An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer

Recruiting now · Not applicable

Conditions studied: Rectal Cancer, Self Efficacy

In brief

The aim of this study is to evaluate the feasibility and acceptability of conducting a randomized trial of a brief psychoeducational intervention versus enhanced usual care for patients with locally advanced rectal cancer who are initiating neoadjuvant multimodality treatment.

Key facts

Study ID

NCT05914766

Run by

Massachusetts General Hospital

People needed

80

Starts

2023-09-21

Expected to finish

2028-12-01

Last updated by the study team

2025-05-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age≥18 years
• Within 8 weeks after documented decision to pursue multi-modality therapy for newly diagnosed LARC (i.e., stage II or III disease)
• Able to complete study procedures English or with the assistance of an interpreter

You may not qualify if…

• Comorbid health condition that would interfere with study participation, as identified by cancer care team
• Has undergone treatment for a prior colorectal cancer

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)
• Dana-Farber Cancer Institute — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.